CCK-4 Antibodies

Santa Cruz Biotechnology provides a broad selection of CCK-4 monoclonal antibodies for research focused on understanding cholecystokinin (CCK) in various physiological processes. CCK-4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cholecystokinin is a key peptide hormone involved in digestion and appetite regulation, playing a crucial role in stimulating the release of digestive enzymes and bile. CCK influences satiety and gastrointestinal motility, making it an important target for research in metabolic disorders and obesity. Research involving CCK can provide insights into therapeutic strategies for various gastrointestinal and metabolic diseases. CCK-4 monoclonal antibodies enable researchers to explore the molecular mechanisms underlying appetite control and digestive processes. Understanding CCK signaling pathways can lead to potential treatments for disorders affecting gastrointestinal function and metabolism. CCK-4 monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing scientific understanding of digestive health and metabolic regulation.